E. M. Frantsiyants

654 total citations
196 papers, 301 citations indexed

About

E. M. Frantsiyants is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, E. M. Frantsiyants has authored 196 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 49 papers in Oncology and 40 papers in Cancer Research. Recurrent topics in E. M. Frantsiyants's work include Cancer, Hypoxia, and Metabolism (22 papers), Growth Hormone and Insulin-like Growth Factors (17 papers) and Cancer Immunotherapy and Biomarkers (10 papers). E. M. Frantsiyants is often cited by papers focused on Cancer, Hypoxia, and Metabolism (22 papers), Growth Hormone and Insulin-like Growth Factors (17 papers) and Cancer Immunotherapy and Biomarkers (10 papers). E. M. Frantsiyants collaborates with scholars based in Russia and United States. E. M. Frantsiyants's co-authors include Oleg I. Kit, Е. И. Сурикова, Svetlana Panina, Tatyana A. Zykova, Yanis Boumber, Alexander Y. Deneka, Elena Ratner, Dmitry S. Petrov, Erica A. Golemis and Lyubov Vladimirova and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

E. M. Frantsiyants

108 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. M. Frantsiyants Russia 7 116 67 51 46 38 196 301
Jing Cheng China 13 134 1.2× 121 1.8× 118 2.3× 115 2.5× 14 0.4× 39 402
C Wolff Chile 12 122 1.1× 58 0.9× 65 1.3× 20 0.4× 4 0.1× 26 355
Stefan‐Martin Brand‐Herrmann Germany 12 190 1.6× 26 0.4× 40 0.8× 36 0.8× 5 0.1× 22 470
Simeng Gu China 9 114 1.0× 27 0.4× 53 1.0× 80 1.7× 4 0.1× 30 274
Yuan Shi China 11 139 1.2× 87 1.3× 113 2.2× 113 2.5× 2 0.1× 39 398
Katherine Clifton United States 10 80 0.7× 113 1.7× 194 3.8× 106 2.3× 4 0.1× 41 398
Paolo Dalino Ciaramella Italy 11 72 0.6× 15 0.2× 81 1.6× 112 2.4× 10 0.3× 21 527
Megan Miller United States 11 156 1.3× 47 0.7× 96 1.9× 29 0.6× 3 0.1× 21 444
Elizabeth Nuttall United States 7 97 0.8× 179 2.7× 71 1.4× 86 1.9× 2 0.1× 10 322

Countries citing papers authored by E. M. Frantsiyants

Since Specialization
Citations

This map shows the geographic impact of E. M. Frantsiyants's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. M. Frantsiyants with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. M. Frantsiyants more than expected).

Fields of papers citing papers by E. M. Frantsiyants

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. M. Frantsiyants. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. M. Frantsiyants. The network helps show where E. M. Frantsiyants may publish in the future.

Co-authorship network of co-authors of E. M. Frantsiyants

This figure shows the co-authorship network connecting the top 25 collaborators of E. M. Frantsiyants. A scholar is included among the top collaborators of E. M. Frantsiyants based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. M. Frantsiyants. E. M. Frantsiyants is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Сурикова, Е. И., et al.. (2025). Free radical oxidation and antioxidant defense in uterine myoma and endometrioid adenocarcinoma depending on its degree of differentiation. SHILAP Revista de lepidopterología. 6(1). 50–59.
2.
Kit, Oleg I., et al.. (2025). PRELIMINARY EVALUATION OF THE ANTITUMOR EFFICACY OF A NEW EPIDERMAL GROWTH FACTOR RECEPTOR BLOCKER. Современные проблемы науки и образования (Modern Problems of Science and Education). 9–9.
3.
Kit, Oleg I., et al.. (2024). Mitochondrial transplantation: new challenges for cancer. SHILAP Revista de lepidopterología. 5(1). 60–70.
5.
Frantsiyants, E. M., et al.. (2024). Thyroid status in patients with early stages of cancer of various localization. SHILAP Revista de lepidopterología. 11(2). 46–56.
6.
Frantsiyants, E. M., et al.. (2024). THYROID STATUS IN ADOLESCENT PATIENTS WITH HODGKIN'S LYMPHOMA BEFORE AND AFTER ANTITUMOR TREATMENT. Современные проблемы науки и образования (Modern Problems of Science and Education). 1–1.
7.
Frantsiyants, E. M., et al.. (2024). Age-related characteristics of the content and activity of certain components of the blood fibrinolytic system in cases of uterine cancer. SHILAP Revista de lepidopterología. 44(4). 105–112. 1 indexed citations
8.
Kit, Oleg I., et al.. (2023). Levels of sex steroids in lung tissues of patients with non‑small cell lung cancer after COVID‑19 of different severity. SHILAP Revista de lepidopterología. 10(2). 10–20.
9.
Zykova, Tatyana A., et al.. (2023). Clinical and morphological features of bladder cancer course in HPV-infected patients. SHILAP Revista de lepidopterología. 4(3). 12–19. 1 indexed citations
10.
Kit, Oleg I., et al.. (2023). MECHANISMS OF NATURAL MITOCHONDRIAL TRANSFER IN HEALTH AND IN CANCER. 14–29. 1 indexed citations
12.
Deneka, Alexander Y., et al.. (2021). Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression. PLoS ONE. 16(7). e0252132–e0252132. 4 indexed citations
13.
Frantsiyants, E. M., et al.. (2020). Features of expression of immunohistochemical markers in local and generalized clear cell kidney cancer. SHILAP Revista de lepidopterología. 7(1). 16–24.
14.
Kit, Oleg I., et al.. (2020). Development of postcastration syndrome and corrective effect of xenon in exponential dose regimen in young patients with gynecological cancers. SHILAP Revista de lepidopterología. 1(3). 6–17. 8 indexed citations
15.
Zykova, Tatyana A., et al.. (2018). Interrelation of HPV-infection of endometry carcinoma and its clinical-morphological features. Advances in molecular oncology. 5(3). 75–82. 2 indexed citations
16.
Kit, Oleg I., et al.. (2017). The activity of proapoptotic genes increases after renal ischemia/reperfusion. Molecular Biology. 51(3). 445–452. 1 indexed citations
17.
Kit, Oleg I., et al.. (2016). Some growth factors in neoplastic tissues of brain tumors of different histological structure. Head and neck tumors (HNT). 6(3). 27–33. 2 indexed citations
18.
Frantsiyants, E. M., et al.. (2015). Growth factors vascular of endothelial and receptors in the dynamic of transplantable melanoma B16/F10 development. Russian Journal of Oncology. 20(2). 32–37. 3 indexed citations
19.
Frantsiyants, E. M., et al.. (2015). Level of certain serum hormones in experimental liver metastasis. Russian Journal of Oncology. 20(3). 49–52. 1 indexed citations
20.
Kit, Oleg I., et al.. (2014). A Method for Reproduction of Metastases in the Liver. Bulletin of Experimental Biology and Medicine. 157(6). 773–775. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026